Neuropediatrics 2014; 45(01): 022-029
DOI: 10.1055/s-0033-1349227
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Neurodevelopmental Outcome during the First Year of Life in Preterm Infants after Supplementation of a Prebiotic Mixture in the Neonatal Period: A Follow-Up Study

Natalie E. LeCouffe
1   Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands
,
Elisabeth A. M. Westerbeek
1   Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands
,
Petra E. M. van Schie
2   Department of Rehabilitation Medicine, (Pediatric) Physiotherapy, VU University Medical Center, Amsterdam, The Netherlands
,
Veronique A. M. Schaaf
2   Department of Rehabilitation Medicine, (Pediatric) Physiotherapy, VU University Medical Center, Amsterdam, The Netherlands
,
Harrie N. Lafeber
1   Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands
,
Ruurd M. van Elburg
1   Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands
3   Danone Research—Center for Specialized Nutrition, Wageningen, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

20. Dezember 2012

08. Mai 2013

Publikationsdatum:
25. Juli 2013 (online)

Preview

Abstract

Aim The study aimed to determine the effect of enteral supplementation of a prebiotic mixture (neutral and acidic oligosaccharides) in the neonatal period on neurodevelopmental outcome in preterm infants with a gestational age of less than 32 weeks and/or birth weight of less than 1,500 g in the first year of life.

Methods Neurodevelopmental outcome consisted of tone and motility according to Touwen, motor ability according to the Alberta Infant Motor Scale, as well as vision and hearing were evaluated at 0, 3, 6, and 12 months corrected age (CA). To adjust for potential confounders, data were analyzed by multinomial or logistic regression.

Results In total, 93 of 101 infants (92%) participated in the study (prebiotic mixture group [n = 48] and placebo group [n = 45]). Incidence of suspect and abnormal neurodevelopmental outcome and delayed motor ability was not different in the prebiotic mixture and placebo group at 0, 3, 6, and 12 months (CA). Infants with 1 or more neonatal infections or more had a higher incidence of abnormal neurodevelopmental outcome (OR: 20.73; 95% CI: 1.31–328.46; p = 0.03) at 6 months CA.

Conclusion Short-term enteral supplementation of a prebiotic mixture in the neonatal period had no effect on neurodevelopmental outcome in preterm infants in the first year of life. However, serious neonatal infections in preterm infants were associated with adverse neurodevelopmental outcome at 6 months, but not at 12 months.